Literature DB >> 11063162

Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy.

K Lång1, L Wikström, A Danielsson, K Tashima, O B Suhr.   

Abstract

BACKGROUND: Gastrointestinal disturbances are important prognostic factors for mortality and morbidity after liver transplantation for familial amyloidotic polyneuropathy (FAP). However, the impact of liver transplantation on malabsorption and bacterial small-bowel contamination has not been evaluated.
METHODS: Twenty-three FAP patients were available for the study. They were examined for gastrointestinal disturbances as a part of the evaluation for liver transplantation for FAP. Bile acid malabsorption was diagnosed with the [75Se]-homocholic acid taurate (SeHCAT) test; fat malabsorption by measuring faecal fat excretion; and bacterial small-bowel contamination with the hydrogen breath test (HBT).
RESULTS: No significant improvement of malabsorption test results were noted from the pre-transplant evaluation 8 months (range, 2-20 months) before transplantation to the post-transplant evaluation performed a median of 20 months (range, 9-62 months) after the procedure. The SeHCAT test result became abnormal in two patients and normal in one, and changes in the test correlated with the time the patients were waiting for transplantation. Faecal fat excretion after transplantation correlated with duration of the disease and with fat excretion before transplantation. A significantly increased fat excretion was noted at the post-transplant evaluation. A change in HBT result was noted in only one patient, in whom the test result became normal; pre-transplant values correlated with those obtained after transplantation.
CONCLUSION: For most FAP patients no improvement in gastrointestinal function was found after transplantation. The finding underlines the importance of an early transplantation before the patients have developed gastrointestinal dysfunction.

Entities:  

Mesh:

Year:  2000        PMID: 11063162     DOI: 10.1080/003655200750023084

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Gastrointestinal Amyloidosis: Approach to Treatment.

Authors:  Peter D. Poullos; Neil Stollman
Journal:  Curr Treat Options Gastroenterol       Date:  2003-02

Review 2.  Systemic amyloidosis and the gastrointestinal tract.

Authors:  Prayman T Sattianayagam; Philip N Hawkins; Julian D Gillmore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-01       Impact factor: 46.802

3.  Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy.

Authors:  J Wixner; P Karling; A Rydh; R Hörnsten; U Wiklund; I Anan; O B Suhr
Journal:  Neurogastroenterol Motil       Date:  2012-08-16       Impact factor: 3.598

4.  Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Torbjörn Sundström; Pontus Karling; Intissar Anan; Ole B Suhr
Journal:  BMC Gastroenterol       Date:  2015-04-25       Impact factor: 3.067

5.  Post hoc analysis of nutritional status in patients with transthyretin familial amyloid polyneuropathy: impact of tafamidis.

Authors:  Ole B Suhr; Isabel M Conceição; Onur N Karayal; Francine S Mandel; Pedro E Huertas; Bo-Göran Ericzon
Journal:  Neurol Ther       Date:  2014-12-11

Review 6.  Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system.

Authors:  Isabel Conceição
Journal:  Clin Auton Res       Date:  2019-08-09       Impact factor: 4.435

7.  Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Konen Obayashi; Yukio Ando; Pontus Karling; Intissar Anan
Journal:  Amyloid       Date:  2013-05-03       Impact factor: 7.141

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.